Biodexa Pharmaceuticals Plc盘中异动急速跳水6.08%报0.770美元_老虎社区_美港股上老虎

Biodexa Pharmaceuticals Plc盘中异动急速跳水6.08%报0.770美元

自选股智能写手04-20

北京时间2024年04月20日00时22分，Biodexa Pharmaceuticals Plc（BDRX.us）股票出现异动，股价大幅下挫6.08%。截至发稿，该股报0.770美元/股，成交量7.6927万股，换手率1.81%，振幅3.88%。最近的财报数据显示，该股实现营业收入367486.39美元，净利润-4.40百万美元，每股收益-17.74美元，毛利--，市盈率-0.00倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2428669923?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-20 00:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2428669923","market":"us","top_or_hot":-1,"title":"Biodexa Pharmaceuticals Plc盘中异动 急速跳水6.08%报0.770美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年04月20日00时22分，Biodexa Pharmaceuticals Plc（BDRX.us）股票出现异动，股价大幅下挫6.08%。截至发稿，该股报0.770美元/股，成交量7.6927万股，换手率1.81%，振幅3.88%。最近的财报数据显示，该股实现营业收入367486.39美元，净利润-4.40百万美元，每股收益-17.74美元，毛利--，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200022467a542692&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biodexa Pharmaceuticals Plc盘中异动 急速跳水6.08%报0.770美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiodexa Pharmaceuticals Plc盘中异动 急速跳水6.08%报0.770美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-20 00:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200022467a542692&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年04月20日00时22分，Biodexa Pharmaceuticals Plc（BDRX.us）股票出现异动，股价大幅下挫6.08%。截至发稿，该股报0.770美元/股，成交量7.6927万股，换手率1.81%，振幅3.88%。最近的财报数据显示，该股实现营业收入367486.39美元，净利润-4.40百万美元，每股收益-17.74美元，毛利--，市盈率-0.00倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200022467a542692&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200022467a542692&s=b","article_id":"2428669923","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200022467a542692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2428669923","pubTimestamp":1713543766,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年04月20日00时22分，Biodexa Pharmaceuticals Plc股票出现异动，股价大幅下挫6.08%。截至发稿，该股报0.770美元/股，成交量7.6927万股，换手率1.81%，振幅3.88%。Biodexa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.00%。Biodexa Pharmaceuticals Plc公司简介：Biodexa Pharmaceuticals Plc 是一家药物输送技术公司，专注于改善药物的生物输送和生物分配。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BDRX":"BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD"},"translate_title":"Biodexa Pharmaceuticals Plc plunged 6.08% to $0.770","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDRX":0.9},"content_text":"北京时间2024年04月20日00时22分，Biodexa Pharmaceuticals Plc（BDRX.us）股票出现异动，股价大幅下挫6.08%。截至发稿，该股报0.770美元/股，成交量7.6927万股，换手率1.81%，振幅3.88%。最近的财报数据显示，该股实现营业收入367486.39美元，净利润-4.40百万美元，每股收益-17.74美元，毛利--，市盈率-0.00倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Biodexa Pharmaceuticals Plc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Lexaria Bioscience Corp C/Wts 14/01/2026 (To Pur Com)、Chromocell Therapeutics Corporation涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为220.57%、12.85%、11.09%，振幅较大的相关个股有Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Chromocell Therapeutics Corporation、Brainstorm Cell Therapeutics Inc.，振幅分别为46.41%、34.28%、30.47%。Biodexa Pharmaceuticals Plc公司简介：Biodexa Pharmaceuticals Plc 是一家药物输送技术公司，专注于改善药物的生物输送和生物分配。 该公司将已批准和正在开发的药物与其专有的创新药物输送技术相结合，以提供具有强大影响患者生活潜力的引人注目的产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}